{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T23:01:59Z","timestamp":1793746919441,"version":"4.6.1"},"reference-count":324,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"vor","delay-in-days":559,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1038\/s41379-021-00779-w","type":"journal-article","created":{"date-parts":[[2021,3,4]],"date-time":"2021-03-04T09:02:56Z","timestamp":1614848576000},"page":"1392-1424","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":245,"title":["New developments in existing WHO entities and evolving molecular concepts: The Genitourinary Pathology Society (GUPS) update on renal neoplasia"],"prefix":"10.1016","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3142-8846","authenticated-orcid":false,"given":"Kiril","family":"Trpkov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ondrej","family":"Hes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3898-1460","authenticated-orcid":false,"given":"Sean R.","family":"Williamson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adebowale J.","family":"Adeniran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0445-8161","authenticated-orcid":false,"given":"Abbas","family":"Agaimy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Alaghehbandan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahul B.","family":"Amin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedram","family":"Argani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5207-3648","authenticated-orcid":false,"given":"Ying-Bei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6049-5293","authenticated-orcid":false,"given":"Liang","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan I.","family":"Epstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John C.","family":"Cheville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Comperat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2029-5139","authenticated-orcid":false,"given":"Isabela Werneck","family":"da Cunha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0745-2160","authenticated-orcid":false,"given":"Jennifer B.","family":"Gordetsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sounak","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiying","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8767-8564","authenticated-orcid":false,"given":"Michelle S.","family":"Hirsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter A.","family":"Humphrey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Payal","family":"Kapur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumiyoshi","family":"Kojima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0842-5348","authenticated-orcid":false,"given":"Jose I.","family":"Lopez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona","family":"Maclean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Magi-Galluzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesse K.","family":"McKenney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6955-8884","authenticated-orcid":false,"given":"Rohit","family":"Mehra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santosh","family":"Menon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3915-9134","authenticated-orcid":false,"given":"George J.","family":"Netto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher G.","family":"Przybycin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priya","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2674-1937","authenticated-orcid":false,"given":"Qiu","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor E.","family":"Reuter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rola M.","family":"Saleeb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajal B.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0982-4607","authenticated-orcid":false,"given":"Steven C.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satish","family":"Tickoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0819-9638","authenticated-orcid":false,"given":"Maria S.","family":"Tretiakova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence","family":"True","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginie","family":"Verkarre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara E.","family":"Wobker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony J.","family":"Gill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/s41379-021-00779-w_bib1","unstructured":"Moch H, Humphrey PA, Ulbright TM, Reuter VE. WHO classification of tumours of the urinary system and male genital organs. 4th edn. Lyon, France: International Agency for Research on Cancer; 2016."},{"key":"10.1038\/s41379-021-00779-w_bib2","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.celrep.2018.03.075","article-title":"The cancer genome atlas comprehensive molecular characterization of renal cell carcinoma","volume":"23","author":"Ricketts","year":"2018","journal-title":"Cell Rep"},{"key":"10.1038\/s41379-021-00779-w_bib3","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/j.ajhg.2013.04.012","article-title":"Germline BAP1 mutations predispose to renal cell carcinomas","volume":"92","author":"Popova","year":"2013","journal-title":"Am J Hum Genet"},{"key":"10.1038\/s41379-021-00779-w_bib4","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1016\/j.juro.2013.06.012","article-title":"Germline PTEN mutation Cowden syndrome: an underappreciated form of hereditary kidney cancer","volume":"190","author":"Shuch","year":"2013","journal-title":"J Urol"},{"key":"10.1038\/s41379-021-00779-w_bib5","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1097\/PAP.0b013e318299b7c6","article-title":"Hereditary syndromes with associated renal neoplasia: a practical guide to histologic recognition in renal tumor resection specimens","volume":"20","author":"Przybycin","year":"2013","journal-title":"Adv Anat Pathol"},{"key":"10.1038\/s41379-021-00779-w_bib6","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.humpath.2013.10.033","article-title":"Clear cell renal cell carcinoma with a syncytial-type multinucleated giant tumor cell component: implications for differential diagnosis","volume":"45","author":"Williamson","year":"2014","journal-title":"Hum Pathol"},{"key":"10.1038\/s41379-021-00779-w_bib7","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.anndiagpath.2018.11.004","article-title":"Papillary pattern in clear cell renal cell carcinoma: Clinicopathologic, morphologic, immunohistochemical and molecular genetic analysis of 23 cases","volume":"38","author":"Alaghehbandan","year":"2019","journal-title":"Ann Diagn Pathol"},{"key":"10.1038\/s41379-021-00779-w_bib8","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/PAS.0000000000001025","article-title":"Architectural Patterns are a Relevant Morphologic Grading System for Clear Cell Renal Cell Carcinoma Prognosis Assessment: Comparisons With WHO\/ISUP Grade and Integrated Staging Systems","volume":"42","author":"Verine","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-021-00779-w_bib9","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/apm.12649","article-title":"CD34 immunostaining enhances a distinct pattern of intratumor angiogenesis with prognostic implications in clear cell renal cell carcinoma","volume":"125","author":"Lopez","year":"2017","journal-title":"APMIS"},{"key":"10.1038\/s41379-021-00779-w_bib10","doi-asserted-by":"crossref","first-page":"102526","DOI":"10.1016\/j.ebiom.2019.10.052","article-title":"Ontological analyses reveal clinically-significant clear cell renal cell carcinoma subtypes with convergent evolutionary trajectories into an aggressive type","volume":"51","author":"Cai","year":"2020","journal-title":"EBioMed"},{"key":"10.1038\/s41379-021-00779-w_bib11","doi-asserted-by":"crossref","unstructured":"Singla N, Xie Z, Zhang Z, Gao M, Yousuf Q, Onabolu O, et al. Pancreatic tropism of metastatic renal cell carcinoma. JCI Insight. 2020;5:e134564.","DOI":"10.1172\/jci.insight.134564"},{"key":"10.1038\/s41379-021-00779-w_bib12","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1200\/JCO.19.01882","article-title":"Results of a multicenter phase II study of atezolizumab and bevacizumab for patients with metastatic renal cell carcinoma with variant histology and\/or sarcomatoid features","volume":"38","author":"McGregor","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1038\/s41379-021-00779-w_bib13","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1097\/PAS.0b013e31821e25cd","article-title":"Role of immunohistochemistry in the evaluation of needle core biopsies in adult renal cortical tumors: an ex vivo study","volume":"35","author":"Al-Ahmadie","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-021-00779-w_bib14","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1111\/j.1365-2559.2011.04074.x","article-title":"Expression of carbonic anhydrase IX in genitourinary and adrenal tumours","volume":"59","author":"Donato","year":"2011","journal-title":"Histopathology"},{"key":"10.1038\/s41379-021-00779-w_bib15","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1309\/AJCPPPR57HNJMSLZ","article-title":"Carbonic anhydrase IX expression in renal neoplasms: correlation with tumor type and grade","volume":"134","author":"Genega","year":"2010","journal-title":"Am J Clin Pathol"},{"key":"10.1038\/s41379-021-00779-w_bib16","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1111\/his.14204","article-title":"Carbonic anhydrase IX (CA9) expression in multiple renal epithelial tumour subtypes","volume":"77","author":"Baniak","year":"2020","journal-title":"Histopathology"},{"key":"10.1038\/s41379-021-00779-w_bib17","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1097\/PAS.0000000000000514","article-title":"Clear cell renal cell carcinoma with borderline features of clear cell papillary renal cell carcinoma: combined morphologic, immunohistochemical, and cytogenetic analysis","volume":"39","author":"Williamson","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-021-00779-w_bib18","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/PAS.0000000000000583","article-title":"Renal neoplasms with overlapping features of clear cell renal cell carcinoma and clear cell papillary renal cell carcinoma: a clinicopathologic study of 37 cases from a single institution","volume":"40","author":"Dhakal","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-021-00779-w_bib19","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1111\/his.13791","article-title":"Reactivity of CK7 across the spectrum of renal cell carcinomas with clear cells","volume":"74","author":"Gonzalez","year":"2019","journal-title":"Histopathology"},{"key":"10.1038\/s41379-021-00779-w_bib20","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1097\/PAS.0000000000001476","article-title":"Report from the international society of urological pathology (ISUP) consultation conference on molecular pathology of urogenital cancers: III: molecular pathology of kidney cancer","volume":"44","author":"Williamson","year":"2020","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-021-00779-w_bib21","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1200\/JCO.2012.45.2003","article-title":"Molecular genetics of clear-cell renal cell carcinoma","volume":"32","author":"Brugarolas","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1038\/s41379-021-00779-w_bib22","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1038\/modpathol.2017.72","article-title":"Renal cell tumors with clear cell histology and intact VHL and chromosome 3p: a histological review of tumors from the Cancer Genome Atlas database","volume":"30","author":"Favazza","year":"2017","journal-title":"Mod Pathol"},{"key":"10.1038\/s41379-021-00779-w_bib23","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.cell.2018.02.020","article-title":"Timing the landmark events in the evolution of clear cell renal cell cancer: TRACERx renal","volume":"173","author":"Mitchell","year":"2018","journal-title":"Cell"},{"key":"10.1038\/s41379-021-00779-w_bib24","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/nature12222","article-title":"Comprehensive molecular characterization of clear cell renal cell carcinoma","volume":"499","author":"Cancer Genome Atlas Research, N.","year":"2013","journal-title":"Nature"},{"key":"10.1038\/s41379-021-00779-w_bib25","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.eururo.2012.09.005","article-title":"Clinical and pathologic impact of select chromatin-modulating tumor suppressors in clear cell renal cell carcinoma","volume":"63","author":"Hakimi","year":"2013","journal-title":"Eur Urol"},{"key":"10.1038\/s41379-021-00779-w_bib26","doi-asserted-by":"crossref","first-page":"4173","DOI":"10.1158\/0008-5472.CAN-13-0360","article-title":"Cooperation and antagonism among cancer genes: the renal cancer paradigm","volume":"73","author":"Pena-Llopis","year":"2013","journal-title":"Cancer Res"},{"key":"10.1038\/s41379-021-00779-w_bib27","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/ng.2323","article-title":"BAP1 loss defines a new class of renal cell carcinoma","volume":"44","author":"Pena-Llopis","year":"2012","journal-title":"Nat Genet"},{"key":"10.1038\/s41379-021-00779-w_bib28","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S1470-2045(12)70584-3","article-title":"Effects on survival of BAP1 and PBRM1 mutations in sporadic clear-cell renal-cell carcinoma: a retrospective analysis with independent validation","volume":"14","author":"Kapur","year":"2013","journal-title":"Lancet Oncol"},{"key":"10.1038\/s41379-021-00779-w_bib29","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1158\/2159-8290.CD-17-0292","article-title":"Modeling renal cell carcinoma in mice: Bap1 and Pbrm1 inactivation drive tumor grade","volume":"7","author":"Gu","year":"2017","journal-title":"Cancer Disco"},{"key":"10.1038\/s41379-021-00779-w_bib30","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1586\/14737159.2015.1068122","article-title":"BAP1, PBRM1 and SETD2 in clear-cell renal cell carcinoma: molecular diagnostics and possible targets for personalized therapies","volume":"15","author":"Piva","year":"2015","journal-title":"Expert Rev Mol Diagn"},{"key":"10.1038\/s41379-021-00779-w_bib31","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.juro.2015.07.113","article-title":"Clear cell renal cell carcinoma subtypes identified by BAP1 and PBRM1 expression","volume":"195","author":"Joseph","year":"2016","journal-title":"J Urol"},{"key":"10.1038\/s41379-021-00779-w_bib32","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.juro.2013.09.041","article-title":"BAP1 immunohistochemistry predicts outcomes in a multi-institutional cohort with clear cell renal cell carcinoma","volume":"191","author":"Kapur","year":"2014","journal-title":"J Urol"},{"key":"10.1038\/s41379-021-00779-w_bib33","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.cell.2018.03.057","article-title":"Tracking cancer evolution reveals constrained routes to metastases: TRACERx renal","volume":"173","author":"Turajlic","year":"2018","journal-title":"Cell"},{"key":"10.1038\/s41379-021-00779-w_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.humpath.2017.02.010","article-title":"Multisite tumor sampling: a new tumor selection method to enhance intratumor heterogeneity detection","volume":"64","author":"Lopez","year":"2017","journal-title":"Hum Pathol"},{"key":"10.1038\/s41379-021-00779-w_bib35","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/j.juro.2009.12.035","article-title":"Histological subtype is an independent predictor of outcome for patients with renal cell carcinoma","volume":"183","author":"Leibovich","year":"2010","journal-title":"J Urol"},{"key":"10.1038\/s41379-021-00779-w_bib36","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1097\/PAS.0b013e318299f0fb","article-title":"The International Society of Urological Pathology (ISUP) grading system for renal cell carcinoma and other prognostic parameters","volume":"37","author":"Delahunt","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-021-00779-w_bib37","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1016\/S0022-5347(05)64153-5","article-title":"An outcome prediction model for patients with clear cell renal cell carcinoma treated with radical nephrectomy based on tumor stage, size, grade and necrosis: the SSIGN score","volume":"168","author":"Frank","year":"2002","journal-title":"J Urol"},{"key":"10.1038\/s41379-021-00779-w_bib38","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1097\/PAS.0b013e31829a85d0","article-title":"Handling and staging of renal cell carcinoma: the International Society of Urological Pathology Consensus (ISUP) conference recommendations","volume":"37","author":"Trpkov","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-021-00779-w_bib39","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1097\/00000478-200010000-00002","article-title":"Renal cell carcinoma with rhabdoid features","volume":"24","author":"Gokden","year":"2000","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-021-00779-w_bib40","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.eururo.2015.01.002","article-title":"Impact of rhabdoid differentiation on prognosis for patients with grade 4 renal cell carcinoma","volume":"68","author":"Zhang","year":"2015","journal-title":"Eur Urol"},{"key":"10.1038\/s41379-021-00779-w_bib41","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1097\/00000478-200404000-00002","article-title":"Sarcomatoid renal cell carcinoma: an examination of underlying histologic subtype and an analysis of associations with patient outcome","volume":"28","author":"Cheville","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-021-00779-w_bib42","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1002\/cncr.21206","article-title":"Histologic coagulative tumor necrosis as a prognostic indicator of renal cell carcinoma aggressiveness","volume":"104","author":"Sengupta","year":"2005","journal-title":"Cancer"},{"key":"10.1038\/s41379-021-00779-w_bib43","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1097\/00000478-200305000-00005","article-title":"Comparisons of outcome and prognostic features among histologic subtypes of renal cell carcinoma","volume":"27","author":"Cheville","year":"2003","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-021-00779-w_bib44","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1097\/PAS.0000000000000251","article-title":"Rhabdoid differentiation is associated with aggressive behavior in renal cell carcinoma: a clinicopathologic analysis of 76 cases with clinical follow-up","volume":"38","author":"Przybycin","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-021-00779-w_bib45","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1111\/his.13672","article-title":"Pathologic staging of renal cell carcinoma: a review of 300 consecutive cases with emphasis on retrograde venous invasion","volume":"73","author":"Taneja","year":"2018","journal-title":"Histopathology"},{"key":"10.1038\/s41379-021-00779-w_bib46","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1038\/modpathol.2011.124","article-title":"Retrograde venous invasion in renal cell carcinoma: a complication of sinus vein and main renal vein invasion","volume":"24","author":"Bonsib","year":"2011","journal-title":"Mod Pathol"},{"key":"10.1038\/s41379-021-00779-w_bib47","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/his.13743","article-title":"Renal cell carcinoma staging: pitfalls, challenges, and updates","volume":"74","author":"Williamson","year":"2019","journal-title":"Histopathology"},{"key":"10.1038\/s41379-021-00779-w_bib48","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1097\/01.ju.0000173631.01329.1f","article-title":"T2 clear cell renal cell carcinoma is a rare entity: a study of 120 clear cell renal cell carcinomas","volume":"174","author":"Bonsib","year":"2005","journal-title":"J Urol"},{"key":"10.1038\/s41379-021-00779-w_bib49","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1053\/hupa.2001.24984","article-title":"Morphologic typing of papillary renal cell carcinoma: comparison of growth kinetics and patient survival in 66 cases","volume":"32","author":"Delahunt","year":"2001","journal-title":"Hum Pathol"},{"key":"10.1038\/s41379-021-00779-w_bib50","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.euf.2016.09.002","article-title":"ntegrated phenotypic\/genotypic analysis of papillary renal cell carcinoma subtypes: identification of prognostic markers, cancer-related pathways, and implications for therapy","volume":"4","author":"Saleeb","year":"2018","journal-title":"Eur Urol Focus"},{"key":"10.1038\/s41379-021-00779-w_bib51","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1097\/PAS.0000000000000962","article-title":"Toward biological subtyping of papillary renal cell carcinoma with clinical implications through histologic, immunohistochemical, and molecular analysis","volume":"41","author":"Saleeb","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-021-00779-w_bib52","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1097\/PAS.0000000000000247","article-title":"The morphologic and immunohistochemical spectrum of papillary renal cell carcinoma: study including 132 cases with pure type 1 and type 2 morphology as well as tumors with overlapping features","volume":"38","author":"Chevarie-Davis","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-021-00779-w_bib53","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1097\/PAS.0000000000001455","article-title":"High WHO\/ISUP grade and unfavorable architecture, rather than typing of papillary renal cell carcinoma, may be associated with worse prognosis","volume":"44","author":"Yang","year":"2020","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-021-00779-w_bib54","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1056\/NEJMoa1505917","article-title":"Comprehensive molecular characterization of papillary renal-cell carcinoma","volume":"374","author":"Cancer Genome Atlas Research","year":"2016","journal-title":"N. Engl J Med"},{"key":"10.1038\/s41379-021-00779-w_bib55","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/gcc.22248","article-title":"Dismantling papillary renal cell carcinoma classification: the heterogeneity of genetic profiles suggests several independent diseases","volume":"54","author":"Marsaud","year":"2015","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1038\/s41379-021-00779-w_bib56","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.anndiagpath.2017.11.004","article-title":"Chromosomal numerical aberration pattern in papillary renal cell carcinoma: Review article","volume":"40","author":"Pitra","year":"2019","journal-title":"Ann Diagn Pathol"},{"key":"10.1038\/s41379-021-00779-w_bib57","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1097\/PAS.0000000000000639","article-title":"Biphasic squamoid alveolar renal cell carcinoma: a distinctive subtype of papillary renal cell carcinoma?","volume":"40","author":"Hes","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-021-00779-w_bib58","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1111\/his.13432","article-title":"Biphasic papillary renal cell carcinoma is a rare morphological variant with frequent multifocality: a study of 28 cases","volume":"72","author":"Trpkov","year":"2018","journal-title":"Histopathology"},{"key":"10.1038\/s41379-021-00779-w_bib59","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/his.13727","article-title":"New and emerging renal entities: a perspective post-WHO 2016 classification","volume":"74","author":"Trpkov","year":"2019","journal-title":"Histopathology"},{"key":"10.1038\/s41379-021-00779-w_bib60","doi-asserted-by":"crossref","unstructured":"Denize T, Just PA, Sibony M, Blons H, Timsit MO, Drossart T, et al. MET alterations in biphasic squamoid alveolar papillary renal cell carcinomas and clinicopathological features. Mod Pathol. 2020. https:\/\/doi.org\/10.1038\/s41379-020-0645-6.","DOI":"10.1038\/s41379-020-0645-6"},{"key":"10.1038\/s41379-021-00779-w_bib61","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.anndiagpath.2017.01.005","article-title":"Warthin-like papillary renal cell carcinoma: Clinicopathologic, morphologic, immunohistochemical and molecular genetic analysis of 11 cases","volume":"27","author":"Skenderi","year":"2017","journal-title":"Ann Diagn Pathol"},{"key":"10.1038\/s41379-021-00779-w_bib62","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.anndiagpath.2016.04.008","article-title":"Solid papillary renal cell carcinoma: clinicopathologic, morphologic, and immunohistochemical analysis of 10 cases and review of the literature","volume":"23","author":"Ulamec","year":"2016","journal-title":"Ann Diagn Pathol"},{"key":"10.1038\/s41379-021-00779-w_bib63","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1097\/PAS.0000000000001288","article-title":"Papillary renal neoplasm with reverse polarity: a morphologic, immunohistochemical, and molecular study","volume":"43","author":"Al-Obaidy","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-021-00779-w_bib64","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1038\/s41379-019-0362-1","article-title":"Recurrent KRAS mutations in papillary renal neoplasm with reverse polarity","volume":"33","author":"Al-Obaidy","year":"2020","journal-title":"Mod Pathol"},{"key":"10.1038\/s41379-021-00779-w_bib65","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.humpath.2007.05.016","article-title":"Papillary renal cell carcinoma with oncocytic cells and nonoverlapping low grade nuclei: expanding the morphologic spectrum with emphasis on clinicopathologic, immunohistochemical and molecular features","volume":"39","author":"Kunju","year":"2008","journal-title":"Hum Pathol"},{"key":"10.1038\/s41379-021-00779-w_bib66","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1038\/s41379-019-0420-8","article-title":"Recurrent KRAS mutations identified in papillary renal neoplasm with reverse polarity-a comparative study with papillary renal cell carcinoma","volume":"33","author":"Kim","year":"2020","journal-title":"Mod Pathol"},{"key":"10.1038\/s41379-021-00779-w_bib67","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1177\/1066896920918289","article-title":"Papillary renal neoplasm with reverse polarity: a clinicopathologic study of 7 Cases","volume":"28","author":"Zhou","year":"2020","journal-title":"Int J Surg Pathol"},{"key":"10.1038\/s41379-021-00779-w_bib68","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1111\/his.14084","article-title":"Frequent KRAS mutations in oncocytic papillary renal neoplasm with inverted nuclei","volume":"76","author":"Tong","year":"2020","journal-title":"Histopathology"},{"key":"10.1038\/s41379-021-00779-w_bib69","doi-asserted-by":"crossref","first-page":"e678","DOI":"10.1016\/j.clgc.2019.03.018","article-title":"Metastatic chromophobe renal cell carcinoma: presence or absence of sarcomatoid differentiation determines clinical course and treatment outcomes","volume":"17","author":"Ged","year":"2019","journal-title":"Clin Genitourin Cancer"},{"key":"10.1038\/s41379-021-00779-w_bib70","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.ccr.2014.07.014","article-title":"The somatic genomic landscape of chromophobe renal cell carcinoma","volume":"26","author":"Davis","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1038\/s41379-021-00779-w_bib71","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.eururo.2020.03.003","article-title":"Next-generation RNA sequencing-based biomarker characterization of chromophobe renal cell carcinoma and related oncocytic neoplasms","volume":"78","author":"Skala","year":"2020","journal-title":"Eur Urol"},{"key":"10.1038\/s41379-021-00779-w_bib72","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1016\/j.celrep.2016.02.024","article-title":"Multilevel genomics-based taxonomy of renal cell carcinoma","volume":"14","author":"Chen","year":"2016","journal-title":"Cell Rep"},{"key":"10.1038\/s41379-021-00779-w_bib73","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.eururo.2020.03.045","article-title":"Novel biomarkers in chromophobe renal cell carcinoma: distinguishing it from its mimics","volume":"78","author":"Drevik","year":"2020","journal-title":"Eur Urol"},{"key":"10.1038\/s41379-021-00779-w_bib74","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1097\/PAS.0b013e3181831e68","article-title":"Chromophobe renal cell carcinoma: histomorphologic characteristics and evaluation of conventional pathologic prognostic parameters in 145 cases","volume":"32","author":"Amin","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-021-00779-w_bib75","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1097\/PAS.0b013e31821a455d","article-title":"Chromophobe renal cell carcinoma: a clinicopathologic study of 203 tumors in 200 patients with primary resection at a single institution","volume":"35","author":"Przybycin","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-021-00779-w_bib76","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1097\/PAS.0b013e318270f71c","article-title":"A novel grading system for clear cell renal cell carcinoma incorporating tumor necrosis","volume":"37","author":"Delahunt","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-021-00779-w_bib77","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0165-4608(88)90219-1","article-title":"Binucleated cells in a human renal cell carcinoma with 34 chromosomes","volume":"31","author":"Kovacs","year":"1988","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1038\/s41379-021-00779-w_bib78","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2407-10-196","article-title":"Genomic expression and single-nucleotide polymorphism profiling discriminates chromophobe renal cell carcinoma and oncocytoma","volume":"10","author":"Tan","year":"2010","journal-title":"BMC Cancer"},{"key":"10.1038\/s41379-021-00779-w_bib79","first-page":"356","article-title":"Specific loss of chromosomes 1, 2, 6, 10, 13, 17, and 21 in chromophobe renal cell carcinomas revealed by comparative genomic hybridization","volume":"145","author":"Speicher","year":"1994","journal-title":"Am J Pathol"},{"key":"10.1038\/s41379-021-00779-w_bib80","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/modpathol.3800286","article-title":"Eosinophilic and classic chromophobe renal cell carcinomas have similar frequent losses of multiple chromosomes from among chromosomes 1, 2, 6, 10, and 17, and this pattern of genetic abnormality is not present in renal oncocytoma","volume":"18","author":"Brunelli","year":"2005","journal-title":"Mod Pathol"},{"key":"10.1038\/s41379-021-00779-w_bib81","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/modpathol.3800739","article-title":"Chromosomal gains in the sarcomatoid transformation of chromophobe renal cell carcinoma","volume":"20","author":"Brunelli","year":"2007","journal-title":"Mod Pathol"},{"key":"10.1038\/s41379-021-00779-w_bib82","doi-asserted-by":"crossref","unstructured":"Alaghehbandan R, Trpkov K, Tretiakova M, Pires-Luis A, Rogala J. Comprehensive review of numerical chromosomal aberrations in chromophobe renal cell carcinoma including its variant morphologies. Adv Anat Pathol. 2020;28:8\u201320.","DOI":"10.1097\/PAP.0000000000000286"},{"key":"10.1038\/s41379-021-00779-w_bib83","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.3390\/cancers11101492","article-title":"Classic chromophobe renal cell carcinoma incur a larger number of chromosomal losses than seen in the eosinophilic subtype","volume":"11","author":"Ohashi","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1038\/s41379-021-00779-w_bib84","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/ng.3146","article-title":"Spectrum of diverse genomic alterations define non-clear cell renal carcinoma subtypes","volume":"47","author":"Durinck","year":"2015","journal-title":"Nat Genet"},{"key":"10.1038\/s41379-021-00779-w_bib85","doi-asserted-by":"crossref","unstructured":"Casuscelli J, Weinhold N, Gundem G, Wang L, Zabor EC, Drill E, et al. Genomic landscape and evolution of metastatic chromophobe renal cell carcinoma. JCI Insight. 2017;2:e92688.","DOI":"10.1172\/jci.insight.92688"},{"key":"10.1038\/s41379-021-00779-w_bib86","doi-asserted-by":"crossref","unstructured":"Roldan-Romero JM, Santos M, Lanillos J, Caleiras E, Anguera G, Maroto P, et al. Molecular characterization of chromophobe renal cell carcinoma reveals mTOR pathway alterations in patients with poor outcome. Mod Pathol. 2020;33:2580\u201390.","DOI":"10.1038\/s41379-020-0607-z"},{"key":"10.1038\/s41379-021-00779-w_bib87","unstructured":"Paner G, Amin M, Moch H, Storkel S. Chromophobe renal cell carcinoma. In: Moch H, Humphrey PA, Ulbright TM, Reuter VE, editors. WHO Classification of Tumours of the Urinary System and Male Genital Organs. Lyon: International Agency for Research on Cancer; 2016. pp. 27\u20138."},{"key":"10.1038\/s41379-021-00779-w_bib88","doi-asserted-by":"crossref","unstructured":"Trpkov K, Williamson SR, Gao Y, Martinek P, Cheng L, Sangoi AR, et al. Low-grade oncocytic tumor of kidney (CD117 Negative, Cytokeratin 7 Positive): a distinct entity? Histopathology. 2019. https:\/\/doi.org\/10.1111\/his.13865.","DOI":"10.1111\/his.13865"},{"key":"10.1038\/s41379-021-00779-w_bib89","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.humpath.2020.07.003","article-title":"Sporadic oncocytic tumors with features intermediate between oncocytoma and chromophobe renal cell carcinoma: comprehensive clinicopathological and genomic profiling","volume":"104","author":"Liu","year":"2020","journal-title":"Hum Pathol"},{"key":"10.1038\/s41379-021-00779-w_bib90","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1097\/PAS.0000000000000248","article-title":"Tuberous sclerosis-associated renal cell carcinoma: a clinicopathologic study of 57 separate carcinomas in 18 patients","volume":"38","author":"Guo","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-021-00779-w_bib91","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1097\/PAS.0000000000001457","article-title":"Eosinophilic renal cell tumors with a TSC and MTOR gene mutations are morphologically and immunohistochemically heterogenous: clinicopathologic and molecular study","volume":"44","author":"Tjota","year":"2020","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-021-00779-w_bib92","doi-asserted-by":"crossref","unstructured":"Tong K, Hu Z. FOXI1 expression in chromophobe renal cell carcinoma and renal oncocytoma: a study of The Cancer Genome Atlas transcriptome-based outlier mining and immunohistochemistry. Virchows Arch. 2020. https:\/\/doi.org\/10.1007\/s00428-020-02900-x.","DOI":"10.1007\/s00428-020-02900-x"},{"key":"10.1038\/s41379-021-00779-w_bib93","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00000478-199701000-00001","article-title":"Renal oncocytoma: a reappraisal of morphologic features with clinicopathologic findings in 80 cases","volume":"21","author":"Amin","year":"1997","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-021-00779-w_bib94","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1111\/j.1365-2559.2010.03726.x","article-title":"Renal oncocytoma revisited: a clinicopathological study of 109 cases with emphasis on problematic diagnostic features","volume":"57","author":"Trpkov","year":"2010","journal-title":"Histopathology"},{"key":"10.1038\/s41379-021-00779-w_bib95","unstructured":"Hes O, Moch H, Reuter V. Oncocytoma. In: Moch H, Humphrey PA, Ulbright TM, Reuter VE, editors. WHO Classification of Tumours of the Urinary System and Male Genital Organs. Lyon: International Agency for Research on Cancer; 2016. pp. 43\u20134."},{"key":"10.1038\/s41379-021-00779-w_bib96","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.humpath.2016.07.020","article-title":"Renal oncocytoma with vascular invasion: a series of 22 cases","volume":"58","author":"Wobker","year":"2016","journal-title":"Hum Pathol"},{"key":"10.1038\/s41379-021-00779-w_bib97","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1097\/00000478-199708000-00001","article-title":"Renal oncocytoma: a clinicopathologic study of 70 cases","volume":"21","author":"Perez-Ordonez","year":"1997","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-021-00779-w_bib98","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1097\/00000478-199909000-00013","article-title":"Renal oncocytosis: a morphologic study of fourteen cases","volume":"23","author":"Tickoo","year":"1999","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-021-00779-w_bib99","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0022-5347(01)62888-X","article-title":"Familial renal oncocytoma: clinicopathological study of 5 families","volume":"160","author":"Weirich","year":"1998","journal-title":"J Urol"},{"key":"10.1038\/s41379-021-00779-w_bib100","first-page":"1257","article-title":"Renal hybrid oncocytic\/chromophobe tumors - a review","volume":"28","author":"Hes","year":"2013","journal-title":"Histol Histopathol"},{"key":"10.1038\/s41379-021-00779-w_bib101","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.humpath.2017.03.004","article-title":"Diagnostic criteria for oncocytic renal neoplasms: a survey of urologic pathologists","volume":"63","author":"Williamson","year":"2017","journal-title":"Hum Pathol"},{"key":"10.1038\/s41379-021-00779-w_bib102","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1097\/PAS.0b013e318164bcbb","article-title":"Clear cell papillary renal cell carcinoma: a distinct histopathologic and molecular genetic entity","volume":"32","author":"Gobbo","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-021-00779-w_bib103","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1038\/modpathol.2011.80","article-title":"Clear-cell papillary renal cell carcinoma: molecular and immunohistochemical analysis with emphasis on the von Hippel-Lindau gene and hypoxia-inducible factor pathway-related proteins","volume":"24","author":"Rohan","year":"2011","journal-title":"Mod Pathol"},{"key":"10.1038\/s41379-021-00779-w_bib104","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/01.pas.0000185382.80844.b1","article-title":"Spectrum of epithelial neoplasms in end-stage renal disease: an experience from 66 tumor-bearing kidneys with emphasis on histologic patterns distinct from those in sporadic adult renal neoplasia","volume":"30","author":"Tickoo","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-021-00779-w_bib105","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.humpath.2013.08.004","article-title":"Clear cell papillary renal cell carcinoma is the fourth most common histologic type of renal cell carcinoma in 290 consecutive nephrectomies for renal cell carcinoma","volume":"45","author":"Zhou","year":"2014","journal-title":"Hum Pathol"},{"key":"10.1038\/s41379-021-00779-w_bib106","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.humpath.2017.11.005","article-title":"Pathologic and clinical characteristics of early onset renal cell carcinoma","volume":"74","author":"Clemmensen","year":"2018","journal-title":"Hum Pathol"},{"key":"10.1038\/s41379-021-00779-w_bib107","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.urology.2016.12.002","article-title":"Clear cell papillary renal cell carcinoma: new clinical and imaging characteristics","volume":"103","author":"Wang","year":"2017","journal-title":"Urology"},{"key":"10.1038\/s41379-021-00779-w_bib108","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.humpath.2019.05.011","article-title":"Clear cell papillary renal cell carcinoma: molecular profile and virtual karyotype","volume":"91","author":"Morlote","year":"2019","journal-title":"Hum Pathol"},{"key":"10.1038\/s41379-021-00779-w_bib109","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1097\/PAS.0000000000000152","article-title":"Papillary cystadenoma of the epididymis and broad ligament: morphologic and immunohistochemical overlap with clear cell papillary renal cell carcinoma","volume":"38","author":"Cox","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-021-00779-w_bib110","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1016\/j.humpath.2014.06.004","article-title":"Clear cell papillary renal cell carcinoma in patients with von Hippel-Lindau syndrome\u2013clinicopathological features and comparative genomic analysis of 3 cases","volume":"45","author":"Rao","year":"2014","journal-title":"Hum Pathol"},{"key":"10.1038\/s41379-021-00779-w_bib111","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1097\/PAS.0b013e318282dab8","article-title":"Clear cell papillary renal cell carcinoma-like tumors in patients with von hippel-lindau disease are unrelated to sporadic clear cell papillary renal cell carcinoma","volume":"37","author":"Williamson","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-021-00779-w_bib112","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1097\/PAS.0000000000001255","article-title":"Genetic underpinnings of renal cell carcinoma with leiomyomatous stroma","volume":"43","author":"Parilla","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-021-00779-w_bib113","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1097\/PAS.0000000000001422","article-title":"\u201cRenal cell carcinoma with leiomyomatous stroma\u201d harbor somatic mutations of TSC1, TSC2, MTOR, and\/or ELOC (TCEB1): clinicopathologic and molecular characterization of 18 sporadic tumors supports a distinct entity","volume":"44","author":"Shah","year":"2020","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-021-00779-w_bib114","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1111\/j.1365-2559.2011.03857.x","article-title":"Clear-cell papillary renal cell carcinoma: 24 cases of a distinct low-grade renal tumour and a comparative genomic hybridization array study of seven cases","volume":"58","author":"Adam","year":"2011","journal-title":"Histopathology"},{"key":"10.1038\/s41379-021-00779-w_bib115","doi-asserted-by":"crossref","unstructured":"Xu J, Reznik E, Lee HJ, Gundem G, Jonsson P, Sarungbam J, et al. Abnormal oxidative metabolism in a quiet genomic background underlies clear cell papillary renal cell carcinoma. Elife. 2019;8;e38986.","DOI":"10.7554\/eLife.38986"},{"key":"10.1038\/s41379-021-00779-w_bib116","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1111\/his.14071","article-title":"Defining clear cell papillary renal cell carcinoma in routine clinical practice","volume":"76","author":"Gupta","year":"2020","journal-title":"Histopathology"},{"key":"10.1038\/s41379-021-00779-w_bib117","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1097\/PAS.0b013e3181872d3f","article-title":"Tubulocystic carcinoma of the kidney: clinicopathologic analysis of 31 cases of a distinctive rare subtype of renal cell carcinoma","volume":"33","author":"Amin","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-021-00779-w_bib118","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s00428-013-1398-0","article-title":"Tubulocystic carcinoma of the kidney: a histologic, immunohistochemical, and ultrastructural study","volume":"462","author":"Alexiev","year":"2013","journal-title":"Virchows Arch"},{"key":"10.1038\/s41379-021-00779-w_bib119","unstructured":"Comperat E, Cheville J, Rioux-Leclerc N. Tubulocystic Renal Cell Carcinoma. In Moch H, Humphrey PA, Ulbright TM, Reutter VE, editors. WHO Classification of Tumours of the Urinary System and Male Genital Organs. 4th edn. Lyon, France: International Agency for Research on Cancer; 2016. p. 38."},{"key":"10.1038\/s41379-021-00779-w_bib120","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1097\/PAI.0000000000000213","volume":"24","author":"Ulamec","year":"2016","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"10.1038\/s41379-021-00779-w_bib121","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1097\/PAS.0b013e3181be22d1","article-title":"Renal tubulocystic carcinoma is closely related to papillary renal cell carcinoma: implications for pathologic classification","volume":"33","author":"Zhou","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-021-00779-w_bib122","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1097\/PAS.0b013e318299f2d1","article-title":"The International Society of Urological Pathology (ISUP) vancouver classification of renal neoplasia","volume":"37","author":"Srigley","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-021-00779-w_bib123","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.urology.2011.01.038","article-title":"Unique case of tubulocystic carcinoma of the kidney with sarcomatoid features: a new entity","volume":"78","author":"Bhullar","year":"2011","journal-title":"Urology"},{"key":"10.1038\/s41379-021-00779-w_bib124","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1016\/j.humpath.2012.11.015","article-title":"Tubulocystic carcinoma of the kidney with poorly differentiated foci: a series of 3 cases with fluorescence in situ hybridization analysis","volume":"44","author":"Al-Hussain","year":"2013","journal-title":"Hum Pathol"},{"key":"10.1038\/s41379-021-00779-w_bib125","first-page":"11124","article-title":"Tubulocystic renal cell carcinoma with poorly differentiated foci is indicative of aggressive behavior: clinicopathologic study of two cases and review of the literature","volume":"8","author":"Zhao","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"key":"10.1038\/s41379-021-00779-w_bib126","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.annpat.2017.05.003","article-title":"Tubulocystic renal cell carcinoma with poorly differentiated foci","volume":"37","author":"Derquin","year":"2017","journal-title":"Ann Pathol"},{"key":"10.1038\/s41379-021-00779-w_bib127","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1111\/his.12840","article-title":"Tubulocystic renal cell carcinoma is an entity that is immunohistochemically and genetically distinct from papillary renal cell carcinoma","volume":"68","author":"Tran","year":"2016","journal-title":"Histopathology"},{"key":"10.1038\/s41379-021-00779-w_bib128","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.path.2015.08.004","article-title":"Emerging entities in renal","volume":"8","author":"Mehra","year":"2015","journal-title":"Neoplasia Surg Pathol Clin"},{"key":"10.1038\/s41379-021-00779-w_bib129","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1097\/PAS.0000000000000719","article-title":"Tubulocystic carcinoma of the kidney with poorly differentiated foci: a frequent morphologic pattern of fumarate hydratase-deficient renal cell carcinoma","volume":"40","author":"Smith","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-021-00779-w_bib130","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1097\/PAS.0000000000000163","article-title":"Hereditary leiomyomatosis and renal cell carcinoma syndrome-associated renal cancer: recognition of the syndrome by pathologic features and the utility of detecting aberrant succination by immunohistochemistry","volume":"38","author":"Chen","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-021-00779-w_bib131","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1097\/PAS.0000000000000617","article-title":"Fumarate hydratase-deficient renal cell carcinoma is strongly correlated with fumarate hydratase mutation and hereditary leiomyomatosis and renal cell carcinoma syndrome","volume":"40","author":"Trpkov","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-021-00779-w_bib132","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1038\/s41379-018-0017-7","volume":"31","author":"Muller","year":"2018","journal-title":"Mod Pathol"},{"key":"10.1038\/s41379-021-00779-w_bib133","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/PAS.0000000000001000","article-title":"Reappraisal of morphologic differences between renal medullary carcinoma, collecting duct carcinoma, and fumarate hydratase-deficient renal cell carcinoma","volume":"42","author":"Ohe","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-021-00779-w_bib134","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1002\/cncy.22071","article-title":"Clues to recognition of fumarate hydratase-deficient renal cell carcinoma: Findings from cytologic and limited biopsy samples","volume":"126","author":"Shyu","year":"2018","journal-title":"Cancer Cytopathol"},{"key":"10.1038\/s41379-021-00779-w_bib135","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1002\/dc.23933","article-title":"Fine-needle aspiration of tubulocystic renal cell carcinoma","volume":"46","author":"Renshaw","year":"2018","journal-title":"Diagn Cytopathol"},{"key":"10.1038\/s41379-021-00779-w_bib136","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/PAS.0b013e318150df1d","article-title":"Tubulocystic carcinoma of the kidney: clinicopathologic and molecular characterization","volume":"32","author":"Yang","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-021-00779-w_bib137","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1136\/jclinpath-2014-202363","article-title":"Gains of chromosomes 7 and 17 in tubulocystic carcinoma of kidney: two cases with fluorescence in situ hybridisation analysis","volume":"67","author":"Chen","year":"2014","journal-title":"J Clin Pathol"},{"key":"10.1038\/s41379-021-00779-w_bib138","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1097\/PAI.0000000000000156","article-title":"Cystic renal oncocytoma and tubulocystic renal cell carcinoma: morphologic and immunohistochemical comparative study","volume":"24","author":"Skenderi","year":"2016","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"10.1038\/s41379-021-00779-w_bib139","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/s41379-018-0185-5","article-title":"Tubulocystic renal cell carcinoma: a distinct clinicopathologic entity with a characteristic genomic profile","volume":"32","author":"Sarungbam","year":"2019","journal-title":"Mod Pathol"},{"key":"10.1038\/s41379-021-00779-w_bib140","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jmoldx.2017.09.002","article-title":"Noncoding RNA expression and targeted next-generation sequencing distinguish tubulocystic renal cell carcinoma (TC-RCC) from other renal neoplasms","volume":"20","author":"Lawrie","year":"2018","journal-title":"J Mol Diagn"},{"key":"10.1038\/s41379-021-00779-w_bib141","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0002-9440(10)61684-7","article-title":"Primary renal neoplasms with the ASPL-TFE3 gene fusion of alveolar soft part sarcoma: a distinctive tumor entity previously included among renal cell carcinomas of children and adolescents","volume":"159","author":"Argani","year":"2001","journal-title":"Am J Pathol"},{"key":"10.1038\/s41379-021-00779-w_bib142","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1097\/00000478-200212000-00003","article-title":"PRCC-TFE3 renal carcinomas: morphologic, immunohistochemical, ultrastructural, and molecular analysis of an entity associated with the t(X;1)(p11.2;q21)","volume":"26","author":"Argani","year":"2002","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-021-00779-w_bib143","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1097\/PAS.0b013e318031ffff","article-title":"Xp11 translocation renal cell carcinoma in adults: expanded clinical, pathologic, and genetic spectrum","volume":"31","author":"Argani","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-021-00779-w_bib144","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1097\/PAS.0b013e31828a69ae","article-title":"Utilization of a TFE3 break-apart FISH assay in a renal tumor consultation service","volume":"37","author":"Green","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-021-00779-w_bib145","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1038\/sj.onc.1201394","article-title":"Fusion of splicing factor genes PSF and NonO (p54nrb) to the TFE3 gene in papillary renal cell carcinoma","volume":"15","author":"Clark","year":"1997","journal-title":"Oncogene"},{"key":"10.1038\/s41379-021-00779-w_bib146","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/sj.onc.1204074","article-title":"The der(17)t(X;17)(p11;q25) of human alveolar soft part sarcoma fuses the TFE3 transcription factor gene to ASPL, a novel gene at 17q25","volume":"20","author":"Ladanyi","year":"2001","journal-title":"Oncogene"},{"key":"10.1038\/s41379-021-00779-w_bib147","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1097\/PAS.0000000000000835","article-title":"RBM10-TFE3 renal cell carcinoma: a potential diagnostic pitfall due to cryptic intrachromosomal Xp11.2 inversion resulting in false-negative TFE3 FISH","volume":"41","author":"Argani","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-021-00779-w_bib148","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1097\/PAS.0000000000000837","article-title":"Xp11 translocation renal cell carcinomas (RCCs) with RBM10-TFE3 gene fusion demonstrating melanotic features and overlapping morphology with t(6;11) RCC: interest and diagnostic pitfall in detecting a paracentric inversion of TFE3","volume":"41","author":"Xia","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-021-00779-w_bib149","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1097\/PAS.0000000000000631","article-title":"TFE3-fusion variant analysis defines specific clinicopathologic associations among Xp11 translocation cancers","volume":"40","author":"Argani","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-021-00779-w_bib150","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1002\/gcc.22261","article-title":"Identification of a novel PARP14-TFE3 gene fusion from 10-year-old FFPE tissue by RNA-seq","volume":"54","author":"Huang","year":"2015","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1038\/s41379-021-00779-w_bib151","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1111\/his.13167","article-title":"Incidence, clinicopathological features and fusion transcript landscape of translocation renal cell carcinomas","volume":"70","author":"Classe","year":"2017","journal-title":"Histopathology"},{"key":"10.1038\/s41379-021-00779-w_bib152","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/s41379-018-0191-7","article-title":"NEAT1-TFE3 and KAT6A-TFE3 renal cell carcinomas, new members of MiT family translocation renal cell carcinoma","volume":"32","author":"Pei","year":"2019","journal-title":"Mod Pathol"},{"key":"10.1038\/s41379-021-00779-w_bib153","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s00428-018-2509-8","article-title":"A novel partner of TFE3 in the Xp11 translocation renal cell carcinoma: clinicopathological analyses and detection of EWSR1-TFE3 fusion","volume":"474","author":"Fukuda","year":"2019","journal-title":"Virchows Arch"},{"key":"10.1038\/s41379-021-00779-w_bib154","doi-asserted-by":"crossref","first-page":"5374","DOI":"10.1038\/sj.onc.1206686","article-title":"A novel CLTC-TFE3 gene fusion in pediatric renal adenocarcinoma with t(X;17)(p11.2;q23)","volume":"22","author":"Argani","year":"2003","journal-title":"Oncogene"},{"key":"10.1038\/s41379-021-00779-w_bib155","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1097\/00000478-200306000-00005","article-title":"Aberrant nuclear immunoreactivity for TFE3 in neoplasms with TFE3 gene fusions: a sensitive and specific immunohistochemical assay","volume":"27","author":"Argani","year":"2003","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-021-00779-w_bib156","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1097\/PAS.0b013e3181dd577e","article-title":"Dual-color, break-apart FISH assay on paraffin-embedded tissues as an adjunct to diagnosis of Xp11 translocation renal cell carcinoma and alveolar soft part sarcoma","volume":"34","author":"Zhong","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-021-00779-w_bib157","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/PDM.0b013e31820e9c67","article-title":"Validation of a TFE3 break-apart FISH assay for Xp11.2 translocation renal cell carcinomas","volume":"20","author":"Mosquera","year":"2011","journal-title":"Diagn Mol Pathol"},{"key":"10.1038\/s41379-021-00779-w_bib158","doi-asserted-by":"crossref","unstructured":"Argani P, Zhang L, Sung YS, White MJ, Miller K, Hopkins M, et al. A novel RBMX-TFE3 gene fusion in a highly aggressive pediatric renal perivascular epithelioid cell tumor. Genes Chromosomes Cancer. 2019. https:\/\/doi.org\/10.1002\/gcc.22801.","DOI":"10.1002\/gcc.22801"},{"key":"10.1038\/s41379-021-00779-w_bib159","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1038\/modpathol.2009.58","article-title":"Cathepsin-K immunoreactivity distinguishes MiTF\/TFE family renal translocation carcinomas from other renal carcinomas","volume":"22","author":"Martignoni","year":"2009","journal-title":"Mod Pathol"},{"key":"10.1038\/s41379-021-00779-w_bib160","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1038\/modpathol.2011.93","article-title":"Differential expression of cathepsin K in neoplasms harboring TFE3 gene fusions","volume":"24","author":"Martignoni","year":"2011","journal-title":"Mod Pathol"},{"key":"10.1038\/s41379-021-00779-w_bib161","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1097\/PAS.0000000000000730","article-title":"TFE3-fusion variant analysis defines specific clinicopathologic associations amog Xp11 translocation cancers","volume":"41","author":"Pivovarcikova","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-021-00779-w_bib162","doi-asserted-by":"crossref","unstructured":"Song Y, Yin X, Xia Q, Zheng L, Yao J, Zeng H, et al. Xp11 translocation renal cell carcinoma with morphological features mimicking multilocular cystic renal neoplasm of low malignant potential: a series of six cases with molecular analysis. J Clin Pathol. 2020. https:\/\/doi.org\/10.1136\/jclinpath-2020-206681.","DOI":"10.1136\/jclinpath-2020-206681"},{"key":"10.1038\/s41379-021-00779-w_bib163","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1097\/PAS.0b013e31824dd972","article-title":"TFE3 rearrangements in adult renal cell carcinoma: clinical and pathologic features with outcome in a large series of consecutively treated patients","volume":"36","author":"Sukov","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-021-00779-w_bib164","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/modpathol.2013.208","article-title":"Clinical heterogeneity of Xp11 translocation renal cell carcinoma: impact of fusion subtype, age, and stage","volume":"27","author":"Ellis","year":"2014","journal-title":"Mod Pathol"},{"key":"10.1038\/s41379-021-00779-w_bib165","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1002\/cncr.23331","article-title":"Translocation renal cell carcinoma: lack of negative impact due to lymph node spread","volume":"112","author":"Geller","year":"2008","journal-title":"Cancer"},{"key":"10.1038\/s41379-021-00779-w_bib166","doi-asserted-by":"crossref","first-page":"3629","DOI":"10.1158\/1078-0432.CCR-19-3283","article-title":"Comprehensive genomic analysis of translocation renal cell carcinoma reveals copy-number variations as drivers of disease progression","volume":"26","author":"Marcon","year":"2020","journal-title":"Clin Cancer Res"},{"key":"10.1038\/s41379-021-00779-w_bib167","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1097\/PAS.0000000000000389","article-title":"Dichotomy of genetic abnormalities in PEComas with therapeutic implications","volume":"39","author":"Agaram","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-021-00779-w_bib168","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1097\/PAS.0000000000000502","volume":"39","author":"Rao","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-021-00779-w_bib169","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1097\/PAS.0b013e3181f17ac0","article-title":"A distinctive subset of PEComas harbors TFE3 gene fusions","volume":"34","author":"Argani","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-021-00779-w_bib170","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/01.pas.0000146007.54092.37","article-title":"Renal carcinomas with the t(6;11)(p21;q12): clinicopathologic features and demonstration of the specific alpha-TFEB gene fusion by immunohistochemistry, RT-PCR, and DNA PCR","volume":"29","author":"Argani","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-021-00779-w_bib171","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1097\/PAS.0000000000000203","article-title":"t(6;11) renal cell carcinoma (RCC): expanded immunohistochemical profile emphasizing novel RCC markers and report of 10 new genetically confirmed cases","volume":"38","author":"Smith","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-021-00779-w_bib172","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1097\/PAS.0b013e3182613d8f","article-title":"Molecular Confirmation of t(6;11)(p21;q12) Renal Cell Carcinoma in Archival Paraffin-embedded Material Using a Break-apart TFEB FISH Assay Expands its Clinicopathologic Spectrum","volume":"36","author":"Argani","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-021-00779-w_bib173","doi-asserted-by":"crossref","unstructured":"Linehan WM, Spellman PT, Ricketts CJ, Creighton CJ, Fei SS, Davis C, et al. Comprehensive molecular characterization of papillary renal-cell carcinoma. N Engl J Med. 2016;374:135\u201345.","DOI":"10.1056\/NEJMoa1505917"},{"key":"10.1038\/s41379-021-00779-w_bib174","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1097\/PAS.0000000000001408","article-title":"Clinicopathologic and molecular analysis of the TFEB fusion variant reveals new members of TFEB translocation renal cell carcinomas (RCCs): expanding the genomic spectrum","volume":"44","author":"Xia","year":"2020","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-021-00779-w_bib175","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.anndiagpath.2014.10.002","article-title":"Aggressive and nonaggressive translocation t(6;11) renal cell carcinoma: comparative study of 6 cases and review of the literature","volume":"18","author":"Peckova","year":"2014","journal-title":"Ann Diagn Pathol"},{"key":"10.1038\/s41379-021-00779-w_bib176","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1097\/PAS.0000000000000720","article-title":"TFEB-amplified renal cell carcinomas: an aggressive molecular subset demonstrating variable melanocytic marker expression and morphologic heterogeneity","volume":"40","author":"Argani","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-021-00779-w_bib177","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/modpathol.2017.99","article-title":"Detection of 6 TFEB-amplified renal cell carcinomas and 25 renal cell carcinomas with MITF translocations: systematic morphologic analysis of 85 cases evaluated by clinical TFE3 and TFEB FISH assays","volume":"31","author":"Skala","year":"2018","journal-title":"Mod Pathol"},{"key":"10.1038\/s41379-021-00779-w_bib178","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/PAS.0000000000000776","article-title":"Renal cell carcinoma with chromosome 6p amplification including the TFEB gene: a novel mechanism of tumor pathogenesis?","volume":"41","author":"Williamson","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-021-00779-w_bib179","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1038\/modpathol.2017.24","article-title":"TFEB-VEGFA (6p21.1) co-amplified renal cell carcinoma: a distinct entity with potential implications for clinical management","volume":"30","author":"Gupta","year":"2017","journal-title":"Mod Pathol"},{"key":"10.1038\/s41379-021-00779-w_bib180","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1097\/PAS.0000000000001307","article-title":"TFEB expression profiling in renal cell carcinomas: clinicopathologic correlations","volume":"43","author":"Gupta","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-021-00779-w_bib181","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1111\/his.13439","article-title":"Novel gene fusion of PRCC-MITF defines a new member of MiT family translocation renal cell carcinoma: clinicopathological analysis and detection of the gene fusion by RNA sequencing and FISH","volume":"72","author":"Xia","year":"2018","journal-title":"Histopathology"},{"key":"10.1038\/s41379-021-00779-w_bib182","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1111\/pin.12718","article-title":"Acquired cystic disease-associated renal cell carcinoma is the most common subtype in long-term dialyzed patients: Central pathology results according to the 2016 WHO classification in a multi-institutional study","volume":"68","author":"Kondo","year":"2018","journal-title":"Pathol Int"},{"key":"10.1038\/s41379-021-00779-w_bib183","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1097\/PAS.0000000000001482","article-title":"Comprehensive clinicopathologic analyses of acquired cystic disease-associated renal cell carcinoma with focus on adverse prognostic factors and metastatic lesions","volume":"44","author":"Kojima","year":"2020","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-021-00779-w_bib184","doi-asserted-by":"crossref","unstructured":"Shah A, Lal P, Toorens E, Palmer MB, Schwartz L, Vergara N, et al. Acquired cystic kidney disease-associated renal cell carcinoma (ACKD-RCC) harbor recurrent mutations in KMT2C and TSC2 genes. Am J Surg Pathol. 2020;44:1479\u201386.","DOI":"10.1097\/PAS.0000000000001530"},{"key":"10.1038\/s41379-021-00779-w_bib185","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1097\/PAS.0000000000001091","article-title":"Acquired cystic disease-associated renal cell carcinoma (ACD-RCC): a multiinstitutional study of 40 cases with clinical follow-up","volume":"42","author":"Przybycin","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-021-00779-w_bib186","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1016\/j.humpath.2014.02.014","article-title":"Pathologic spectrum of cysts in end-stage kidneys: possible precursors to renal neoplasia","volume":"45","author":"Hosseini","year":"2014","journal-title":"Hum Pathol"},{"key":"10.1038\/s41379-021-00779-w_bib187","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1097\/PAS.0000000000000557","article-title":"Atypical renal cysts: a morphologic, immunohistochemical, and molecular study","volume":"40","author":"Matoso","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-021-00779-w_bib188","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1053\/hupa.2002.125370","article-title":"Atypical epithelial proliferations in acquired renal cystic disease harbor cytogenetic aberrations","volume":"33","author":"Cheuk","year":"2002","journal-title":"Hum Pathol"},{"key":"10.1038\/s41379-021-00779-w_bib189","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1097\/PAS.0000000000001124","article-title":"Acquired cystic disease-associated renal cell carcinoma (ACKD-RCC)-like Cysts","volume":"42","author":"Sun","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-021-00779-w_bib190","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s00795-009-0465-8","article-title":"Acquired cystic disease-associated renal cell carcinoma with gain of chromosomes 3, 7, and 16, gain of chromosome X, and loss of chromosome Y","volume":"43","author":"Kuroda","year":"2010","journal-title":"Med Mol Morphol"},{"key":"10.1038\/s41379-021-00779-w_bib191","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1365-2559.2009.03361.x","article-title":"Immunohistochemical and molecular genetic profiling of acquired cystic disease-associated renal cell carcinoma","volume":"55","author":"Pan","year":"2009","journal-title":"Histopathology"},{"key":"10.1038\/s41379-021-00779-w_bib192","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1097\/PAS.0b013e3182635954","article-title":"Carcinoma of the collecting ducts of Bellini and renal medullary carcinoma: clinicopathologic analysis of 52 cases of rare aggressive subtypes of renal cell carcinoma with a focus on their interrelationship","volume":"36","author":"Gupta","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-021-00779-w_bib193","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/pin.12667","article-title":"High grade infiltrative adenocarcinomas of renal cell origin: New insights into classification, morphology, and molecular pathogenesis","volume":"68","author":"Singh","year":"2018","journal-title":"Pathol Int"},{"key":"10.1038\/s41379-021-00779-w_bib194","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1158\/1078-0432.CCR-17-3296","article-title":"A model linking sickle cell hemoglobinopathies and SMARCB1 loss in renal medullary carcinoma","volume":"24","author":"Msaouel","year":"2018","journal-title":"Clin Cancer Res"},{"key":"10.1038\/s41379-021-00779-w_bib195","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1097\/PAS.0000000000000222","article-title":"Collecting duct carcinoma versus renal medullary carcinoma: an appeal for nosologic and biological clarity","volume":"38","author":"Amin","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-021-00779-w_bib196","unstructured":"Amin M, Merino M. Renal medullary carcinoma. In: 2016 WHO classification of tumors of hte urinary system and male genital organs. Lyon; 2016. pp. 31\u20132."},{"key":"10.1038\/s41379-021-00779-w_bib197","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1111\/bju.13705","article-title":"Management and outcomes of patients with renal medullary carcinoma: a multicentre collaborative study","volume":"120","author":"Shah","year":"2017","journal-title":"BJU Int"},{"key":"10.1038\/s41379-021-00779-w_bib198","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1097\/PAS.0b013e3182770406","article-title":"Renal medullary carcinoma: molecular, immunohistochemistry, and morphologic correlation","volume":"37","author":"Liu","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-021-00779-w_bib199","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/j.1365-2559.2012.04228.x","article-title":"SMARCB1\/INI1 inactivation in renal medullary carcinoma","volume":"61","author":"Calderaro","year":"2012","journal-title":"Histopathology"},{"key":"10.1038\/s41379-021-00779-w_bib200","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1097\/PAS.0000000000000787","article-title":"Rhabdoid and undifferentiated phenotype in renal cell carcinoma: analysis of 32 cases indicating a distinctive common pathway of dedifferentiation frequently associated with SWI\/SNF complex deficiency","volume":"41","author":"Agaimy","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-021-00779-w_bib201","doi-asserted-by":"crossref","unstructured":"Agaimy A, Amin MB, Gill AJ, Popp B, Reis A, Berney DM, et al. SWI\/SNF protein expression status in fumarate hydratase-deficient renal cell carcinoma: immunohistochemical analysis of 32 tumors from 28 patients. Hum Pathol. 2018;77:139\u201346.","DOI":"10.1016\/j.humpath.2018.04.004"},{"key":"10.1038\/s41379-021-00779-w_bib202","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1097\/PAS.0b013e3182417d78","article-title":"Expression of OCT3\/4 in renal medullary carcinoma represents a potential diagnostic pitfall","volume":"36","author":"Rao","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-021-00779-w_bib203","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1038\/s41379-019-0273-1","article-title":"Distinctive mechanisms underlie the loss of SMARCB1 protein expression in renal medullary carcinoma: morphologic and molecular analysis of 20 cases","volume":"32","author":"Jia","year":"2019","journal-title":"Mod Pathol"},{"key":"10.1038\/s41379-021-00779-w_bib204","doi-asserted-by":"crossref","unstructured":"Msaouel P, Malouf GG, Su X, Yao H, Tripathi DN, Soeung M, et al. Comprehensive molecular characterization identifies distinct genomic and immune hallmarks of renal medullary carcinoma. Cancer Cell. 2020;37:720\u201334.","DOI":"10.1016\/j.ccell.2020.04.002"},{"key":"10.1038\/s41379-021-00779-w_bib205","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/j.eururo.2015.09.027","article-title":"Balanced translocations disrupting SMARCB1 are hallmark recurrent genetic alterations in renal medullary carcinomas","volume":"69","author":"Calderaro","year":"2016","journal-title":"Eur Urol"},{"key":"10.1038\/s41379-021-00779-w_bib206","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.humpath.2017.07.006","article-title":"Renal cell carcinoma, unclassified with medullary phenotype: poorly differentiated adenocarcinomas overlapping with renal medullary carcinoma","volume":"67","author":"Sirohi","year":"2017","journal-title":"Hum Pathol"},{"key":"10.1038\/s41379-021-00779-w_bib207","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1111\/pin.12858","article-title":"A case of renal cell carcinoma unclassified with medullary phenotype without detectable gene deletion","volume":"69","author":"Tsuzuki","year":"2019","journal-title":"Pathol Int"},{"key":"10.1038\/s41379-021-00779-w_bib208","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1097\/PAT.0000000000000175","article-title":"Renal cell carcinoma with rhabdoid features and loss of INI1 expression in an individual without sickle cell trait","volume":"46","author":"Scarpelli","year":"2014","journal-title":"Pathology"},{"key":"10.1038\/s41379-021-00779-w_bib209","doi-asserted-by":"crossref","first-page":"3757","DOI":"10.21873\/anticanres.12657","article-title":"Renal cell carcinoma, unclassified with medullary phenotype and synchronous renal clear cell carcinoma present in a patient with no sickle cell trait\/disease: diagnostic and therapeutic challenges","volume":"38","author":"Lai","year":"2018","journal-title":"Anticancer Res"},{"key":"10.1038\/s41379-021-00779-w_bib210","first-page":"1782","article-title":"Coexistent loss of INI1 and BRG1 expression in a rhabdoid renal cell carcinoma (RCC): implications for a possible role of SWI\/SNF complex in the pathogenesis of RCC","volume":"7","author":"Rao","year":"2014","journal-title":"Int J Clin Exp Pathol"},{"key":"10.1038\/s41379-021-00779-w_bib211","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.clgc.2018.09.005","article-title":"Updated recommendations on the diagnosis, management, and clinical trial eligibility criteria for patients with renal medullary carcinoma","volume":"17","author":"Msaouel","year":"2019","journal-title":"Clin Genitourin Cancer"},{"key":"10.1038\/s41379-021-00779-w_bib212","unstructured":"Hong AL, Tseng YY, Wala JA, Kim WJ, Kynnap BD, Doshi MB, et al. Renal medullary carcinomas depend upon SMARCB1 loss and are sensitive to proteasome inhibition. Elife. 2019;8;e44161."},{"key":"10.1038\/s41379-021-00779-w_bib213","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1002\/gcc.22847","article-title":"Novel renal medullary carcinoma cell lines, UOK353 and UOK360, provide preclinical tools to identify new therapeutic treatments","volume":"59","author":"Wei","year":"2020","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1038\/s41379-021-00779-w_bib214","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.eururo.2015.06.019","article-title":"Characterization of clinical cases of collecting duct carcinoma of the kidney assessed by comprehensive genomic profiling","volume":"70","author":"Pal","year":"2016","journal-title":"Eur Urol"},{"key":"10.1038\/s41379-021-00779-w_bib215","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/his.12524","article-title":"Metastases to the kidney: a clinicopathological study of 43 cases with an emphasis on deceptive features","volume":"66","author":"Wu","year":"2015","journal-title":"Histopathology"},{"key":"10.1038\/s41379-021-00779-w_bib216","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1111\/bju.13194","article-title":"Metastases to the kidney: a comprehensive analysis of 151 patients from a tertiary referral centre","volume":"117","author":"Zhou","year":"2016","journal-title":"BJU Int"},{"key":"10.1038\/s41379-021-00779-w_bib217","doi-asserted-by":"crossref","unstructured":"Sirohi D, Vaske C, Sanborn Z, Smith SC, Don MD, Lindsey KG, et al. Polyoma virus-associated carcinomas of the urologic tract: a clinicopathologic and molecular study. Mod Pathol. 2018. https:\/\/doi.org\/10.1038\/s41379-018-0065-z.","DOI":"10.1038\/s41379-018-0065-z"},{"key":"10.1038\/s41379-021-00779-w_bib218","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1038\/s41379-020-0489-0","article-title":"Variant morphology and random chromosomal integration of BK polyomavirus in posttransplant urothelial carcinomas","volume":"33","author":"Bertz","year":"2020","journal-title":"Mod Pathol"},{"key":"10.1038\/s41379-021-00779-w_bib219","doi-asserted-by":"crossref","unstructured":"Yang C, Cimera RS, Aryeequaye R, Jayakumaran G, Sarungbam J, Al-Ahmadie HA, et al. Adverse histology, homozygous loss of CDKN2A\/B, and complex genomic alterations in locally advanced\/metastatic renal mucinous tubular and spindle cell carcinoma. Mod Pathol. 2021;34:445\u201356.","DOI":"10.1038\/s41379-020-00667-9"},{"key":"10.1038\/s41379-021-00779-w_bib220","doi-asserted-by":"crossref","DOI":"10.1038\/srep30988","article-title":"Unique transcriptomic profile of collecting duct carcinomas relative to upper tract urothelial carcinomas and other kidney carcinomas","volume":"6","author":"Malouf","year":"2016","journal-title":"Sci Rep"},{"key":"10.1038\/s41379-021-00779-w_bib221","doi-asserted-by":"crossref","first-page":"e78137","DOI":"10.1371\/journal.pone.0078137","article-title":"Collecting duct carcinomas represent a unique tumor entity based on genetic alterations","volume":"8","author":"Becker","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1038\/s41379-021-00779-w_bib222","doi-asserted-by":"crossref","first-page":"29901","DOI":"10.18632\/oncotarget.9093","article-title":"Collecting duct carcinoma of the kidney is associated with CDKN2A deletion and SLC family gene up-regulation","volume":"7","author":"Wang","year":"2016","journal-title":"Oncotarget"},{"key":"10.1038\/s41379-021-00779-w_bib223","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms13131","article-title":"Molecular analysis of aggressive renal cell carcinoma with unclassified histology reveals distinct subsets","volume":"7","author":"Chen","year":"2016","journal-title":"Nat Commun"},{"key":"10.1038\/s41379-021-00779-w_bib224","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1097\/01.MP.0000031709.40712.46","article-title":"Low-grade tubular-mucinous renal neoplasms: morphologic, immunohistochemical, and genetic features","volume":"15","author":"Rakozy","year":"2002","journal-title":"Mod Pathol"},{"key":"10.1038\/s41379-021-00779-w_bib225","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1158\/2159-8290.CD-16-0267","article-title":"Biallelic alteration and dysregulation of the hippo pathway in mucinous tubular and spindle cell carcinoma of the kidney","volume":"6","author":"Mehra","year":"2016","journal-title":"Cancer Disco"},{"key":"10.1038\/s41379-021-00779-w_bib226","doi-asserted-by":"crossref","unstructured":"Ren Q, Wang L, Al-Ahmadie HA, Fine SW, Gopalan A, Sirintrapun SJ, et al. Distinct genomic copy number alterations distinguish mucinous tubular and spindle cell carcinoma of the kidney from papillary renal cell carcinoma with overlapping histologic features. Am J Surg Pathol. 2018;42:767\u201377.","DOI":"10.1097\/PAS.0000000000001038"},{"key":"10.1038\/s41379-021-00779-w_bib227","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.anndiagpath.2006.09.005","article-title":"Mucinous tubular and spindle cell carcinoma of kidney is probably a variant of papillary renal cell carcinoma with spindle cell features","volume":"11","author":"Shen","year":"2007","journal-title":"Ann Diagn Pathol"},{"key":"10.1038\/s41379-021-00779-w_bib228","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/01.pas.0000180443.94645.50","article-title":"Immunohistochemical analysis of mucinous tubular and spindle cell carcinoma and papillary renal cell carcinoma of the kidney: significant immunophenotypic overlap warrants diagnostic caution","volume":"30","author":"Paner","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-021-00779-w_bib229","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1097\/PAS.0b013e3181829ed5","article-title":"Mucinous tubular and spindle cell carcinoma of the kidney with sarcomatoid change","volume":"33","author":"Dhillon","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-021-00779-w_bib230","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.anndiagpath.2015.04.004","article-title":"Mucinous spindle and tubular renal cell carcinoma: analysis of chromosomal aberration pattern of low-grade, high-grade, and overlapping morphologic variant with papillary renal cell carcinoma","volume":"19","author":"Peckova","year":"2015","journal-title":"Ann Diagn Pathol"},{"key":"10.1038\/s41379-021-00779-w_bib231","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1097\/PAS.0000000000001150","article-title":"VSTM2A overexpression is a sensitive and specific biomarker for mucinous tubular and spindle cell carcinoma (MTSCC) of the kidney","volume":"42","author":"Wang","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-021-00779-w_bib232","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/j.humpath.2007.10.006","article-title":"Mucinous tubular and spindle cell carcinoma with aggressive histomorphology\u2013a sarcomatoid variant","volume":"39","author":"Pillay","year":"2008","journal-title":"Hum Pathol"},{"key":"10.1038\/s41379-021-00779-w_bib233","first-page":"180","article-title":"Mucinous tubular and spindle cell carcinoma of the kidney with sarcomatoid differentiation","volume":"1","author":"Simon","year":"2008","journal-title":"Int J Clin Exp Pathol"},{"key":"10.1038\/s41379-021-00779-w_bib234","first-page":"1517","article-title":"Mucinous tubular and spindle cell carcinoma with Fuhrman nuclear grade 3: a histological, immunohistochemical, ultrastructural and FISH study","volume":"23","author":"Kuroda","year":"2008","journal-title":"Histol Histopathol"},{"key":"10.1038\/s41379-021-00779-w_bib235","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/bju.12992","article-title":"Mucinous tubular and spindle cell carcinoma (MTSCC) of the kidney: a detailed study of radiological, pathological and clinical outcomes","volume":"116","author":"Kenney","year":"2015","journal-title":"BJU Int"},{"key":"10.1038\/s41379-021-00779-w_bib236","doi-asserted-by":"crossref","unstructured":"Sadimin ET, Chen YB, Wang L, Argani P, Epstein JI. Chromosomal abnormalities of high grade mucinous tubular and spindle cell carcinoma of the kidney. Histopathology. 2017;71:719\u201324.","DOI":"10.1111\/his.13298"},{"key":"10.1038\/s41379-021-00779-w_bib237","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.clgc.2019.04.006","article-title":"Mucinous tubular and spindle-cell carcinoma of the kidney: clinical features, genomic profiles, and treatment outcomes","volume":"17","author":"Ged","year":"2019","journal-title":"Clin Genitourin Cancer"},{"key":"10.1038\/s41379-021-00779-w_bib238","doi-asserted-by":"crossref","unstructured":"Adamane SA, Menon S, Prakash G, Bakshi G, Joshi A, Popat P, et al. Mucinous tubular and spindle cell carcinoma of the kidney: A case series with a brief review of the literature. Indian J Cancer. 2020;57:267\u201381.","DOI":"10.4103\/ijc.IJC_642_18"},{"key":"10.1038\/s41379-021-00779-w_bib239","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.humpath.2010.07.018","article-title":"Mucinous tubular and spindle cell carcinoma of kidney without sarcomatoid change showing metastases to liver and retroperitoneal lymph node","volume":"42","author":"Ursani","year":"2011","journal-title":"Hum Pathol"},{"key":"10.1038\/s41379-021-00779-w_bib240","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.anndiagpath.2011.04.001","article-title":"Metastatic renal mucinous tubular and spindle cell carcinoma. Atypical behavior of a rare, morphologically bland tumor","volume":"16","author":"Thway","year":"2012","journal-title":"Ann Diagn Pathol"},{"key":"10.1038\/s41379-021-00779-w_bib241","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1046\/j.1365-2559.2002.01515.x","article-title":"Spindle and cuboidal renal cell carcinoma, a tumour having frequent association with nephrolithiasis: report of 11 cases including a case with hybrid conventional renal cell carcinoma\/ spindle and cuboidal renal cell carcinoma components","volume":"41","author":"Hes","year":"2002","journal-title":"Histopathology"},{"key":"10.1038\/s41379-021-00779-w_bib242","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.anndiagpath.2010.08.003","article-title":"High-grade mucinous tubular and spindle cell carcinoma: comparative genomic hybridization study","volume":"15","author":"Kuroda","year":"2011","journal-title":"Ann Diagn Pathol"},{"key":"10.1038\/s41379-021-00779-w_bib243","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/00000478-200104000-00002","article-title":"The spectrum of metanephric adenofibroma and related lesions: clinicopathologic study of 25 cases from the National Wilms Tumor Study Group Pathology Center","volume":"25","author":"Arroyo","year":"2001","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-021-00779-w_bib244","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1097\/PAS.0000000000000501","article-title":"Application of BRAF V600E mutation analysis for the diagnosis of metanephric adenofibroma","volume":"39","author":"Mangray","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-021-00779-w_bib245","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/j.humpath.2015.03.019","article-title":"BRAF mutations in pediatric metanephric tumors","volume":"46","author":"Chami","year":"2015","journal-title":"Hum Pathol"},{"key":"10.1038\/s41379-021-00779-w_bib246","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1097\/PAS.0000000000000603","article-title":"Frequent BRAF V600E mutations in metanephric stromal tumor","volume":"40","author":"Argani","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-021-00779-w_bib247","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.humpath.2016.09.025","article-title":"BRAF exon 15 mutations in pediatric renal stromal tumors: prevalence in metanephric stromal tumors","volume":"60","author":"Marsden","year":"2017","journal-title":"Hum Pathol"},{"key":"10.1038\/s41379-021-00779-w_bib248","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1111\/his.12509","article-title":"Immunohistochemical staining for BRAF V600E supports the diagnosis of metanephric adenoma","volume":"66","author":"Pinto","year":"2015","journal-title":"Histopathology"},{"key":"10.1038\/s41379-021-00779-w_bib249","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1097\/PAS.0000000000000377","article-title":"Molecular and immunohistochemical characterization reveals novel BRAF mutations in metanephric adenoma","volume":"39","author":"Udager","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-021-00779-w_bib250","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.humpath.2020.10.013","article-title":"Renal neoplasia with papillary architecture involving the pelvicalyceal system","volume":"107","author":"Gupta","year":"2020","journal-title":"Hum Pathol"},{"key":"10.1038\/s41379-021-00779-w_bib251","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.eururo.2012.05.051","article-title":"BRAF mutations in metanephric adenoma of the kidney","volume":"62","author":"Choueiri","year":"2012","journal-title":"Eur Urol"},{"key":"10.1038\/s41379-021-00779-w_bib252","doi-asserted-by":"crossref","first-page":"54096","DOI":"10.18632\/oncotarget.11117","article-title":"Distinct clinicopathological features in metanephric adenoma harboring BRAF mutation","volume":"8","author":"Calio","year":"2017","journal-title":"Oncotarget"},{"key":"10.1038\/s41379-021-00779-w_bib253","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1097\/PAS.0000000000001240","article-title":"Metanephric adenoma-epithelial wilms tumor overlap lesions: an analysis of BRAF status","volume":"43","author":"Wobker","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-021-00779-w_bib254","doi-asserted-by":"crossref","unstructured":"Obasaju P, Shahab S, Dunn E, Rhee DS, Jiang L, Dome JS, et al. BRAF V600E-mutated metastatic pediatric Wilms tumor with complete response to targeted RAF\/MEK inhibition. Cold Spring Harb Mol Case Stud. 2020;6:e004820.","DOI":"10.1101\/mcs.a004820"},{"key":"10.1038\/s41379-021-00779-w_bib255","doi-asserted-by":"crossref","first-page":"e721","DOI":"10.1016\/j.clgc.2019.02.012","article-title":"Successful treatment of metastatic adult wilms tumor with anti-BRAF treatment: a case report and a brief review of the literature","volume":"17","author":"de Vries-Brilland","year":"2019","journal-title":"Clin Genitourin Cancer"},{"key":"10.1038\/s41379-021-00779-w_bib256","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1111\/his.14094","article-title":"Molecular characterisation of metanephric adenomas beyond BRAF: genetic evidence for potential malignant evolution","volume":"76","author":"Chan","year":"2020","journal-title":"Histopathology"},{"key":"10.1038\/s41379-021-00779-w_bib257","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s13000-018-0732-x","article-title":"Novel clinicopathological and molecular characterization of metanephric adenoma: a study of 28 cases","volume":"13","author":"Ding","year":"2018","journal-title":"Diagn Pathol"},{"key":"10.1038\/s41379-021-00779-w_bib258","doi-asserted-by":"crossref","unstructured":"Kuroda N, Trpkov K, Gao Y, Tretiakova M, Liu YJ, Ulamec M, et al. ALK rearranged renal cell carcinoma (ALK-RCC): a multi-institutional study of twelve cases with identification of novel partner genes CLIP1, KIF5B and KIAA1217. Mod Pathol. 2020;33:2564\u201379.","DOI":"10.1038\/s41379-020-0578-0"},{"key":"10.1038\/s41379-021-00779-w_bib259","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1200\/JCO.2013.50.8192","article-title":"Defining early-onset kidney cancer: implications for germline and somatic mutation testing and clinical management","volume":"32","author":"Shuch","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1038\/s41379-021-00779-w_bib260","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/nrurol.2010.47","article-title":"The genetic basis of kidney cancer: a metabolic disease","volume":"7","author":"Linehan","year":"2010","journal-title":"Nat Rev Urol"},{"key":"10.1038\/s41379-021-00779-w_bib261","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1002\/ijc.10513","article-title":"A population-based familial aggregation analysis indicates genetic contribution in a majority of renal cell carcinomas","volume":"100","author":"Gudbjartsson","year":"2002","journal-title":"Int J Cancer"},{"key":"10.1038\/s41379-021-00779-w_bib262","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.eururo.2019.06.015","article-title":"Familial kidney cancer: implications of new syndromes and molecular insights","volume":"76","author":"Carlo","year":"2019","journal-title":"Eur Urol"},{"key":"10.1038\/s41379-021-00779-w_bib263","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/gim.2014.147","article-title":"A practice guideline from the American College of Medical Genetics and Genomics and the National Society of Genetic Counselors: referral indications for cancer predisposition assessment","volume":"17","author":"Hampel","year":"2015","journal-title":"Genet Med"},{"key":"10.1038\/s41379-021-00779-w_bib264","unstructured":"EVIQ. https:\/\/www.eviq.org.au\/cancer-genetics\/referral-guidelines\/1146-referral-guidelines-for-kidney-cancer-risk-as. 2020."},{"key":"10.1038\/s41379-021-00779-w_bib265","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1007\/s10689-014-9735-2","article-title":"Hereditary leiomyomatosis and renal cell cancer (HLRCC): renal cancer risk, surveillance and treatment","volume":"13","author":"Menko","year":"2014","journal-title":"Fam Cancer"},{"key":"10.1038\/s41379-021-00779-w_bib266","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1097\/PAS.0000000000000573","article-title":"Fumarate hydratase-deficient uterine leiomyomas occur in both the syndromic and sporadic settings","volume":"40","author":"Harrison","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-021-00779-w_bib267","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/his.13402","article-title":"Pathology and genetics of phaeochromocytoma and paraganglioma","volume":"72","author":"Turchini","year":"2018","journal-title":"Histopathology"},{"key":"10.1038\/s41379-021-00779-w_bib268","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/PAS.0000000000001372","article-title":"A clinicopathologic and molecular analysis of fumarate hydratase-deficient renal cell carcinoma in 32 patients","volume":"44","author":"Lau","year":"2020","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-021-00779-w_bib269","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s00428-015-1783-y","article-title":"Genetic testing of leiomyoma tissue in women younger than 30 years old might provide an effective screening approach for the hereditary leiomyomatosis and renal cell cancer syndrome (HLRCC)","volume":"467","author":"Martinek","year":"2015","journal-title":"Virchows Arch"},{"key":"10.1038\/s41379-021-00779-w_bib270","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1097\/PAS.0b013e31804375b8","article-title":"The morphologic spectrum of kidney tumors in hereditary leiomyomatosis and renal cell carcinoma (HLRCC) syndrome","volume":"31","author":"Merino","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-021-00779-w_bib271","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1111\/cge.13014","article-title":"Reassessing the clinical spectrum associated with hereditary leiomyomatosis and renal cell carcinoma syndrome in French FH mutation carriers","volume":"92","author":"Muller","year":"2017","journal-title":"Clin Genet"},{"key":"10.1038\/s41379-021-00779-w_bib272","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/his.13183","article-title":"A distinctive, low-grade oncocytic fumarate hydratase-deficient renal cell carcinoma, morphologically reminiscent of succinate dehydrogenase-deficient renal cell carcinoma","volume":"71","author":"Smith","year":"2017","journal-title":"Histopathology"},{"key":"10.1038\/s41379-021-00779-w_bib273","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1111\/his.13395","article-title":"Re-evaluation of 33 \u2018unclassified\u2019 eosinophilic renal cell carcinomas in young patients","volume":"72","author":"Li","year":"2018","journal-title":"Histopathology"},{"key":"10.1038\/s41379-021-00779-w_bib274","doi-asserted-by":"crossref","unstructured":"Gupta S, Swanson AA, Chen YB, Lopez T, Milosevic D, Kipp BR, et al. Incidence of succinate dehydrogenase and fumarate hydratase-deficient renal cell carcinoma based on immunohistochemical screening with SDHA\/SDHB and FH\/2SC. Hum Pathol. 2019;91:114\u201322.","DOI":"10.1016\/j.humpath.2019.07.004"},{"key":"10.1038\/s41379-021-00779-w_bib275","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/PAT.0b013e3283539932","article-title":"Succinate dehydrogenase (SDH) and mitochondrial driven neoplasia","volume":"44","author":"Gill","year":"2012","journal-title":"Pathology"},{"key":"10.1038\/s41379-021-00779-w_bib276","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/his.13277","article-title":"Succinate dehydrogenase (SDH)-deficient neoplasia","volume":"72","author":"Gill","year":"2018","journal-title":"Histopathology"},{"key":"10.1038\/s41379-021-00779-w_bib277","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1097\/PAS.0000000000000149","article-title":"Succinate dehydrogenase deficiency is rare in pituitary adenomas","volume":"38","author":"Gill","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-021-00779-w_bib278","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1097\/PAS.0b013e3181d6150d","article-title":"Immunohistochemistry for SDHB divides gastrointestinal stromal tumors (GISTs) into 2 distinct types","volume":"34","author":"Gill","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-021-00779-w_bib279","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1097\/PAS.0000000000001415","article-title":"Morphologic clues to succinate dehydrogenase (SDH) deficiency in pheochromocytomas and paragangliomas","volume":"44","author":"Turchini","year":"2020","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-021-00779-w_bib280","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1097\/PAS.0b013e318227e7f4","article-title":"Renal tumors associated with germline SDHB mutation show distinctive morphology","volume":"35","author":"Gill","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-021-00779-w_bib281","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1097\/PAS.0000000000000292","article-title":"Succinate dehydrogenase (SDH)-deficient renal carcinoma: a morphologically distinct entity: a clinicopathologic series of 36 tumors from 27 patients","volume":"38","author":"Gill","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-021-00779-w_bib282","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/modpathol.2014.86","article-title":"Succinate dehydrogenase-deficient renal cell carcinoma: detailed characterization of 11 tumors defining a unique subtype of renal cell carcinoma","volume":"28","author":"Williamson","year":"2015","journal-title":"Mod Pathol"},{"key":"10.1038\/s41379-021-00779-w_bib283","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1097\/PAT.0000000000000018","article-title":"Germline SDHC mutation presenting as recurrent SDH deficient GIST and renal carcinoma","volume":"45","author":"Gill","year":"2013","journal-title":"Pathology"},{"key":"10.1038\/s41379-021-00779-w_bib284","doi-asserted-by":"crossref","first-page":"E1472","DOI":"10.1210\/jc.2011-1043","article-title":"SDHA immunohistochemistry detects germline SDHA gene mutations in apparently sporadic paragangliomas and pheochromocytomas","volume":"96","author":"Korpershoek","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1038\/s41379-021-00779-w_bib285","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1097\/PAS.0000000000000403","article-title":"A novel SDHA-deficient renal cell carcinoma revealed by comprehensive genomic profiling","volume":"39","author":"Yakirevich","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-021-00779-w_bib286","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1016\/j.humpath.2015.07.027","article-title":"Renal carcinoma associated with a novel succinate dehydrogenase A mutation: a case report and review of literature of a rare subtype of renal carcinoma","volume":"46","author":"Ozluk","year":"2015","journal-title":"Hum Pathol"},{"key":"10.1038\/s41379-021-00779-w_bib287","first-page":"12188","article-title":"A novel germline mutation in SDHA identified in a rare case of gastrointestinal stromal tumor complicated with renal cell carcinoma","volume":"8","author":"Jiang","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"key":"10.1038\/s41379-021-00779-w_bib288","article-title":"SDH-deficient renal cell carcinoma associated with biallelic mutation in succinate dehydrogenase A: comprehensive genetic profiling and its relation to therapy response","volume":"2","author":"McEvoy","year":"2018","journal-title":"NPJ Precis Oncol"},{"key":"10.1038\/s41379-021-00779-w_bib289","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1136\/jmedgenet-2018-105427","article-title":"Bayesian approach to determining penetrance of pathogenic SDH variants","volume":"55","author":"Benn","year":"2018","journal-title":"J Med Genet"},{"key":"10.1038\/s41379-021-00779-w_bib290","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1097\/PAS.0b013e3182671155","article-title":"Loss of SDHA expression identifies SDHA mutations in succinate dehydrogenase-deficient gastrointestinal stromal tumors","volume":"37","author":"Dwight","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-021-00779-w_bib291","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/nrurol.2015.206","article-title":"Molecular genetics and clinical features of Birt-Hogg-Dube syndrome","volume":"12","author":"Schmidt","year":"2015","journal-title":"Nat Rev Urol"},{"key":"10.1038\/s41379-021-00779-w_bib292","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jdermsci.2017.10.014","article-title":"Skin lesions of Birt-Hogg-Dube syndrome: Clinical and histopathological findings in 31 Japanese patients who presented with pneumothorax and\/or multiple lung cysts","volume":"89","author":"Iwabuchi","year":"2018","journal-title":"J Dermatol Sci"},{"key":"10.1038\/s41379-021-00779-w_bib293","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1136\/jclinpath-2012-201200","article-title":"Birt-Hogg-Dube syndrome: clinicopathological features of the lung","volume":"66","author":"Furuya","year":"2013","journal-title":"J Clin Pathol"},{"key":"10.1038\/s41379-021-00779-w_bib294","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/cge.12807","article-title":"Genetic, epidemiologic and clinicopathologic studies of Japanese Asian patients with Birt-Hogg-Dube syndrome","volume":"90","author":"Furuya","year":"2016","journal-title":"Clin Genet"},{"key":"10.1038\/s41379-021-00779-w_bib295","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1097\/00000478-200212000-00002","article-title":"Renal tumors in the Birt-Hogg-Dube syndrome","volume":"26","author":"Pavlovich","year":"2002","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-021-00779-w_bib296","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/cas.14255","article-title":"Birt-Hogg-Dube syndrome-associated renal cell carcinoma: Histopathological features and diagnostic conundrum","volume":"111","author":"Furuya","year":"2020","journal-title":"Cancer Sci"},{"key":"10.1038\/s41379-021-00779-w_bib297","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.ajpath.2015.10.013","article-title":"Genome-wide uniparental disomy and copy number variations in renal cell carcinomas associated with Birt-Hogg-Dube syndrome","volume":"186","author":"Iribe","year":"2016","journal-title":"Am J Pathol"},{"key":"10.1038\/s41379-021-00779-w_bib298","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1038\/modpathol.2015.101","article-title":"Mitochondrial DNA mutations distinguish bilateral multifocal renal oncocytomas from familial Birt-Hogg-Dube tumors","volume":"28","author":"Lang","year":"2015","journal-title":"Mod Pathol"},{"key":"10.1038\/s41379-021-00779-w_bib299","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1097\/PAS.0000000000000632","article-title":"Renal cell carcinoma occurring in patients with prior neuroblastoma: a heterogenous group of neoplasms","volume":"40","author":"Falzarano","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-021-00779-w_bib300","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.humpath.2020.07.014","article-title":"Secondary renal neoplasia following chemotherapy or radiation in pediatric patients","volume":"103","author":"Gupta","year":"2020","journal-title":"Hum Pathol"},{"key":"10.1038\/s41379-021-00779-w_bib301","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1200\/JCO.2005.04.4693","article-title":"Translocation carcinomas of the kidney after chemotherapy in childhood","volume":"24","author":"Argani","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1038\/s41379-021-00779-w_bib302","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1093\/jnci\/djt014","article-title":"Renal carcinoma after childhood cancer: a report from the childhood cancer survivor study","volume":"105","author":"Wilson","year":"2013","journal-title":"J Natl Cancer Inst"},{"key":"10.1038\/s41379-021-00779-w_bib303","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1002\/ajmg.a.33384","article-title":"Paraganglioma, neuroblastoma, and a SDHB mutation: Resolution of a 30-year-old mystery","volume":"152A","author":"Schimke","year":"2010","journal-title":"Am J Med Genet A"},{"key":"10.1038\/s41379-021-00779-w_bib304","doi-asserted-by":"crossref","first-page":"248","DOI":"10.2350\/10-07-0871-CR.1","article-title":"Rhabdomyosarcoma-associated renal cell carcinoma: a link with constitutional Tp53 mutation","volume":"14","author":"Curry","year":"2011","journal-title":"Pediatr Dev Pathol"},{"key":"10.1038\/s41379-021-00779-w_bib305","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1097\/PAS.0000000000000508","article-title":"Eosinophilic, solid, and cystic renal cell carcinoma: clinicopathologic study of 16 unique, sporadic neoplasms occurring in women","volume":"40","author":"Trpkov","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-021-00779-w_bib306","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1097\/PAS.0000000000000838","article-title":"Eosinophilic solid and cystic renal cell carcinoma (ESC RCC): further morphologic and molecular characterization of ESC RCC as a distinct entity","volume":"41","author":"Trpkov","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-021-00779-w_bib307","doi-asserted-by":"crossref","first-page":"3","DOI":"10.5114\/pjp.2015.51147","article-title":"Review of renal cell carcinoma with rhabdoid features with focus on clinical and pathobiological aspects","volume":"66","author":"Kuroda","year":"2015","journal-title":"Pol J Pathol"},{"key":"10.1038\/s41379-021-00779-w_bib308","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.urolonc.2019.05.012","article-title":"Impact of rhabdoid differentiation on postoperative outcome for patients with N0M0 renal cell carcinoma","volume":"37","author":"Kim","year":"2019","journal-title":"Urol Oncol"},{"key":"10.1038\/s41379-021-00779-w_bib309","doi-asserted-by":"crossref","DOI":"10.1186\/s12894-020-0584-z","article-title":"Impact of sarcomatoid differentiation and rhabdoid differentiation on prognosis for renal cell carcinoma with vena caval tumour thrombus treated surgically","volume":"20","author":"Yang","year":"2020","journal-title":"BMC Urol"},{"key":"10.1038\/s41379-021-00779-w_bib310","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/bju.12781","article-title":"A novel prognostic model for patients with sarcomatoid renal cell carcinoma","volume":"115","author":"Zhang","year":"2015","journal-title":"BJU Int"},{"key":"10.1038\/s41379-021-00779-w_bib311","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.humpath.2014.09.001","article-title":"Genetic alterations in renal cell carcinoma with rhabdoid differentiation","volume":"46","author":"Perrino","year":"2015","journal-title":"Hum Pathol"},{"key":"10.1038\/s41379-021-00779-w_bib312","doi-asserted-by":"crossref","unstructured":"Kinoshita F, Kohashi K, Sugimoto M, Takamatsu D, Kiyozawa D, Eto M, et al. The SWI\/SNF chromatin-remodeling complex status in renal cell carcinomas with sarcomatoid or rhabdoid features. Virchows Arch. 2020. https:\/\/doi.org\/10.1007\/s00428-020-02839-z.","DOI":"10.1007\/s00428-020-02839-z"},{"key":"10.1038\/s41379-021-00779-w_bib313","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1038\/modpathol.2015.68","article-title":"Intratumoral morphologic and molecular heterogeneity of rhabdoid renal cell carcinoma: challenges for personalized therapy","volume":"28","author":"Singh","year":"2015","journal-title":"Mod Pathol"},{"key":"10.1038\/s41379-021-00779-w_bib314","doi-asserted-by":"crossref","first-page":"6686","DOI":"10.1158\/1078-0432.CCR-17-1057","article-title":"Sarcomatoid renal cell carcinoma has a distinct molecular pathogenesis, driver mutation profile, and transcriptional landscape","volume":"23","author":"Wang","year":"2017","journal-title":"Clin Cancer Res"},{"key":"10.1038\/s41379-021-00779-w_bib315","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.eururo.2016.01.051","article-title":"Genomic characterization of renal cell carcinoma with sarcomatoid dedifferentiation pinpoints recurrent genomic alterations","volume":"70","author":"Malouf","year":"2016","journal-title":"Eur Urol"},{"key":"10.1038\/s41379-021-00779-w_bib316","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-57534-5","article-title":"Molecular characterization of sarcomatoid clear cell renal cell carcinoma unveils new candidate oncogenic drivers","volume":"10","author":"Malouf","year":"2020","journal-title":"Sci Rep"},{"key":"10.1038\/s41379-021-00779-w_bib317","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.6004\/jnccn.2019.0054","article-title":"NCCN Guidelines Insights: Kidney Cancer, Version 2.2020","volume":"17","author":"Motzer","year":"2019","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1038\/s41379-021-00779-w_bib318","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/s41585-020-0282-3","article-title":"Checkpoint inhibitor immunotherapy in kidney cancer","volume":"17","author":"Xu","year":"2020","journal-title":"Nat Rev Urol"},{"key":"10.1038\/s41379-021-00779-w_bib319","doi-asserted-by":"crossref","unstructured":"Motzer RJ, Escudier B, McDermott DF, Aren Frontera O, Melichar B, Powles T, et al. Survival outcomes and independent response assessment with nivolumab plus ipilimumab versus sunitinib in patients with advanced renal cell carcinoma: 42-month follow-up of a randomized phase 3 clinical trial. J Immunother Cancer. 2020;8;e000891.","DOI":"10.1136\/jitc-2020-000891corr1"},{"key":"10.1038\/s41379-021-00779-w_bib320","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1158\/2326-6066.CIR-15-0150","article-title":"PD-1 and PD-L1 expression in renal cell carcinoma with sarcomatoid differentiation","volume":"3","author":"Joseph","year":"2015","journal-title":"Cancer Immunol Res"},{"key":"10.1038\/s41379-021-00779-w_bib321","doi-asserted-by":"crossref","first-page":"4823","DOI":"10.1002\/cncr.30937","article-title":"Programmed cell death ligand 1 and tumor-infiltrating lymphocyte status in patients with renal cell carcinoma and sarcomatoid dedifferentiation","volume":"123","author":"Kawakami","year":"2017","journal-title":"Cancer"},{"key":"10.1038\/s41379-021-00779-w_bib322","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1038\/s41379-019-0269-x","article-title":"JAK2\/PD-L1\/PD-L2 (9p24.1) amplifications in renal cell carcinomas with sarcomatoid transformation: implications for clinical management","volume":"32","author":"Gupta","year":"2019","journal-title":"Mod Pathol"},{"key":"10.1038\/s41379-021-00779-w_bib323","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.humpath.2020.04.003","article-title":"Programmed death ligand 1\/indoleamine 2,3-dioxygenase 1 expression and tumor-infiltrating lymphocyte status in renal cell carcinoma with sarcomatoid changes and rhabdoid features","volume":"101","author":"Kiyozawa","year":"2020","journal-title":"Hum Pathol"},{"key":"10.1038\/s41379-021-00779-w_bib324","doi-asserted-by":"crossref","unstructured":"Tannir NM, Signoretti S, Choueiri TK, McDermott DF, Motzer RJ, Flaifel A, et al. Efficacy and safety of nivolumab plus ipilimumab versus sunitinib in first-line treatment of patients with advanced sarcomatoid renal cell carcinoma. Clin Cancer Res. 2021:27:78\u201386.","DOI":"10.1158\/1078-0432.CCR-20-2063"}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41379-021-00779-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41379-021-00779-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222005907?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222005907?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41379-021-00779-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T00:38:22Z","timestamp":1760229502000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0893395222005907"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":324,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["S0893395222005907"],"URL":"https:\/\/doi.org\/10.1038\/s41379-021-00779-w","relation":{},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"New developments in existing WHO entities and evolving molecular concepts: The Genitourinary Pathology Society (GUPS) update on renal neoplasia","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/s41379-021-00779-w","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}]}}